Vanguard Asset Management »

Janux Therapeutics shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $340k 24k 13.90

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Henderson Group
State Street Corporation
FMR
Vanguard Group
Prosight Management
Vanguard Capital Management
TCG Crossover Management
Wellington Management Company
Alyeska Investment Group
Vanguard Portfolio Management
Deep Track Capital
Point72 Asset Management
Geode Capital Management

View all funds holding Janux Therapeutics